Hospital Vall d´Hebrón
Barcelona 8035
0 studies enrolling now · 15 studies all time
What they study most
Advanced Cholangiocarcinoma, Alzheimer's Disease, Bronchiectasis, Cerebroside Lipidosis Syndrome, Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial, Chronic Lymphocytic Leukemia, Gaucher Disease, Non-Neuronopathic Form, Gaucher Disease, Type 1, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Hyperbilirubinemia, Neonatal, Leukemia, Myeloid, Acute
Studies at this site
- A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy — Completed
- eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients — Running, not enrolling
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
- Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) — Completed
- A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth — Completed
- Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer — Stopped early
- Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer — Stopped early
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia — Stopped early
- Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia — Stopped early
- A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease — Completed
- Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer — Completed
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer — Completed
- Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease — Completed
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
- A Non-Interventional Follow-Up to the VELOUR Study - Translational Research — Status unconfirmed